BIIE-0246

BIIE-0246

Cat. No.: DIA-0231170

Size: 1 mg Size: 50 mg Size: Customer Size
Product Information
CAS No. 246146-55-4
Chemical Name (2S)-5-(diaminomethylideneamino)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-2-[[2-[1-[2-oxo-2-[4-(6-oxo-5,11-dihydrobenzo[c][1]benzazepin-11-yl)piperazin-1-yl]ethyl]cyclopentyl]acetyl]amino]pentanamide
Formula C49H57N11O6
Molecular Weight 896.06
PubChem CID 9811493
SMILES C1CCC(C1)(CC(=O)NC(CCCN=C(N)N)C(=O)NCCN2C(=O)N(N(C2=O)C3=CC=CC=C3)C4=CC=CC=C4)CC(=O)N5CCN(CC5)C6C7=CC=CC=C7C(=O)NC8=CC=CC=C68
Target Receptors
Product Description Potent, selective, competitive non-peptide antagonist for neuropeptide Y Y2 receptor
Format & Storage
Purity > 98%
Shipping Shipped on dry ice.
Storage Store at -20 °C.
Solubility Overview >50 mg/mL in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top